Randomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal Hypertension

NCT01456286 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Liver Cirrhosis
Portal Hypertension

Interventions

DRUG: sapropterin

Sponsor

Fundacion Clinic per a la Recerca Biomédica